Derivation of Huntington's disease-affected human embryonic stem cell lines

Area of Science:

• Stem Cell Biology
• Neurodegenerative Diseases
• Genetics

Background:

• Huntington's disease (HD) is a fatal autosomal dominant neurodegenerative disorder.
• It is caused by an abnormal expansion of cytosine-adenine-guanine (CAG) repeats within the Huntingtin gene (Htt).
• Developing cellular models is crucial for understanding HD pathogenesis and therapeutic strategies.

Purpose of the Study:

• To derive and characterize human embryonic stem cell (hESC) lines modeling Huntington's disease.
• To provide a valuable research tool for investigating HD mechanisms and potential treatments.
• To establish well-characterized, pluripotent HD-hESC lines for the scientific community.

Main Methods:

• Generation of four hESC lines with expanded CAG repeats (≥40) in the Htt gene.
• Derivation of a normal sibling-matched control hESC line.
• Characterization of pluripotency markers (Oct4, SSEA3, Tra-1-81), karyotype, and differentiation potential (teratoma and neuronal differentiation assays).

Main Results:

• Successfully derived four HD-hESC lines (SIVF017-HD, SIVF018-HD, SIVF020-HD, SIVF046-HD) and one control line (SIVF019).
• All lines exhibited normal karyotypes, expressed key pluripotency markers, and maintained pluripotency over multiple passages.
• HD-hESC lines demonstrated differentiation capacity into three germ layers and generated MAP2-positive neuronal cells expressing Htt protein.

Conclusions:

• The established HD-hESC lines are confirmed pluripotent stem cell lines.
• These cell lines serve as a critical resource for studying Huntington's disease.
• Availability of these models will accelerate research into HD pathogenesis and the development of novel therapeutics.